These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21512174)

  • 1. A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators.
    Ogata T; Nagakane Y; Christensen S; Ma H; Campbell BC; Churilov L; Olivot JM; Desmond PM; Albers GW; Davis SM; Donnan GA;
    Stroke; 2011 Jun; 42(6):1596-601. PubMed ID: 21512174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
    Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
    Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study.
    Ogata T; Christensen S; Nagakane Y; Ma H; Campbell BC; Churilov L; Lansberg MG; Straka M; De Silva DA; Mlynash M; Bammer R; Olivot JM; Desmond PM; Albers GW; Davis SM; Donnan GA;
    Stroke; 2013 Jan; 44(1):87-93. PubMed ID: 23250996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmentation of the classical magnetic resonance mismatch "penumbral" pattern with time.
    Ma H; Zavala JA; Teoh H; Churilov L; Gunawan M; Ly J; Wright P; Phan T; Arakawa S; Davis SM; Donnan GA
    Stroke; 2009 Dec; 40(12):3752-7. PubMed ID: 19850896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome.
    Ma H; Wright P; Allport L; Phan TG; Churilov L; Ly J; Zavala JA; Arakawa S; Campbell B; Davis SM; Donnan GA
    Int J Stroke; 2015 Jun; 10(4):565-70. PubMed ID: 24612428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration.
    Nagakane Y; Christensen S; Brekenfeld C; Ma H; Churilov L; Parsons MW; Levi CR; Butcher KS; Peeters A; Barber PA; Bladin CF; De Silva DA; Fink J; Kimber TE; Schultz DW; Muir KW; Tress BM; Desmond PM; Davis SM; Donnan GA;
    Stroke; 2011 Jan; 42(1):59-64. PubMed ID: 21127303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.
    Legrand L; Tisserand M; Turc G; Edjlali M; Calvet D; Trystram D; Roca P; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
    Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
    Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hidden mismatch: an explanation for infarct growth without perfusion-weighted imaging/diffusion-weighted imaging mismatch in patients with acute ischemic stroke.
    Ma HK; Zavala JA; Churilov L; Ly J; Wright PM; Phan TG; Arakawa S; Davis SM; Donnan GA
    Stroke; 2011 Mar; 42(3):662-8. PubMed ID: 21293017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the perfusion/diffusion and diffusion/FLAIR mismatch: data from the AXIS2 trial.
    Wouters A; Dupont P; Ringelstein EB; Norrving B; Chamorro A; Grond M; Laage R; Schneider A; Wilms G; Thomalla G; Lemmens R; Thijs VN
    J Cereb Blood Flow Metab; 2015 Oct; 35(10):1681-6. PubMed ID: 26036936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between lesion location and functional outcome after ischemic stroke.
    Yassi N; Churilov L; Campbell BC; Sharma G; Bammer R; Desmond PM; Parsons MW; Albers GW; Donnan GA; Davis SM; ;
    Int J Stroke; 2015 Dec; 10(8):1270-6. PubMed ID: 26045301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Mismatch Concepts for Magnetic Resonance Imaging-Guided Thrombolysis in Unknown Onset Stroke.
    Scheldeman L; Wouters A; Boutitie F; Dupont P; Christensen S; Cheng B; Ebinger M; Endres M; Fiebach JB; Gerloff C; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thijs V; Thomalla G; Lemmens R;
    Ann Neurol; 2020 Jun; 87(6):931-938. PubMed ID: 32227638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.
    Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Yavagal DR; Saver JL
    Stroke; 2015 Oct; 46(10):2786-94. PubMed ID: 26316344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.